
Rona Yaeger, MD
Gastrointestinal Oncologist & Early Drug Development Specialist
Titles
Associate Attending Physician
Clinical Expertise
Colorectal Cancer; Gastrointestinal Malignancies
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Yaeger accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-888-5109 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, New York University
Residencies
Internal Medicine - Columbia University Medical Center
Fellowships
Medical Oncology - Memorial Sloan Kettering Cancer Center; Medicine - Weill Cornell Medical College
Board Certifications
Internal Medicine; Medical Oncology
I am a medical oncologist who specializes in treating people with cancers of the colon and rectum. I also care for people with anal squamous cell cancer, carcinoid tumors, and other gastrointestinal tract cancers.
Read more
My clinical and laboratory research at Memorial Sloan Kettering center on understanding molecular subsets of colorectal cancer and developing new therapies based on this understanding. My work focuses on colorectal tumors with mutations in the BRAF or RAS genes, and I am leading our clinical trial program for colorectal tumors that harbor BRAF mutations. I both treat patients and perform laboratory research and believe that my experiences in each realm inform my work and make me a better researcher. Ultimately, I aim to use our insights into cancer cell biology to help guide the care of our patients and to develop more rationally designed clinical trials that test mechanism-based therapeutic strategies.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Yaeger
- A Phase 1 Study of PF-07799933 Alone or with Binimetinib or Cetuximab in People with Solid Tumors
- A Phase I/II Study of MRTX849 in Patients with KRAS G12C-positive Cancers
- A Phase II Study of Different Treatments for People with Stage III Colon Cancer Who Received Chemotherapy and Are Having Testing for Tumor DNA in the Blood
- A Phase III Study of MRTX849 Combined with Cetuximab versus Chemotherapy in People with KRAS G12C-Mutated Advanced Colorectal Cancer that Continues to Grow
Read more
- A Phase III Study of Nivolumab plus Chemotherapy for Patients with Advanced Anal Cancer
- Clinical Trials Co-Investigated by Dr. Yaeger
- A Phase 1 Study of CFT1946 in People With Solid Tumors Containing Mutations in BRAF-V600
- A Phase 1 Study of RMC-6291 in People with KRAS-Mutated Solid Tumors
- A Phase I Study of ASP3082 in People with Solid Tumors with KRAS G12D Mutations
- A Phase I Study of BGB-3245 in Patients with Metastatic Solid Tumors that Continue to Grow Despite Treatment
- A Phase I Study of LY3537982 in People with Solid Tumors with a G12C Mutation in the KRAS Gene
- A Phase I Study of PF-07284892 in People with Advanced Solid Tumors
- A Phase I Study of RMC-6236 in People with Advanced Solid Tumors Containing Specific KRAS Mutations
- A Phase I/IIA Study of PLX8394 in Patients with Advanced Inoperable Solid Tumors
- A Phase IB Study of AMG 510 Combined with Other Drugs to Treat Metastatic Solid Tumors with the KRAS G12C mutation
- A Phase IB/IIA Study of Mirdametinib on Its Own or in Combination with Fulvestrant in People with Advanced Breast Cancer and Other Solid Tumors with Certain Genetic Changes
- A Phase II Study of LUT014 in People with Acneiform Rash from Colorectal Cancer Treatment
- A Phase II Study of Tucatinib and Trastuzumab Followed by Chemotherapy as Initial Treatment for Locally Advanced HER2-Positive Rectal Cancer
- A Phase III Study of Tucatinib with Trastuzumab and mFOLFOX6 Chemotherapy versus Standard Care as Initial Treatment for HER2+ Metastatic Colorectal Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Yaeger’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Rona Yaeger discloses the following relationships and financial interests:
-
Medscape
Provision of Services -
Mirati Therapeutics
Provision of Services
-
PER Events, LLC
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].